Due to a production error, the article type of this article mislabeled as Clinical Trial. The correct article type is Study Protocol.

The publisher apologizes for this mistake.

The original version of this article has been updated.

The publisher apologizes for this mistake. The original version of this article has been updated.

Keywords: cancer, metastasis, colorectal cancer, breast cancer, imipramine, Fascin1, tumor invasion, histology

Citation: Frontiers Production Office (2024) Erratum: Effects of imipramine on cancer patients over-expressing Fascin1; description of the HITCLIF clinical trial. Front. Oncol. 14:1405306. doi: 10.3389/fonc.2024.1405306

Received: 22 March 2024; Accepted: 22 March 2024;
Published: 16 April 2024.

Copyright © 2024 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, production.office@frontiersin.org